CHRAC1

chromatin accessibility complex subunit 1, the group of Chromatin accessibility complex

Basic information

Region (hg38): 8:140511311-140517154

Links

ENSG00000104472NCBI:54108OMIM:607268HGNC:13544Uniprot:Q9NRG0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CHRAC1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHRAC1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
1
clinvar
4
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 3 1 0

Variants in CHRAC1

This is a list of pathogenic ClinVar variants found in the CHRAC1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-140511510-T-C not specified Uncertain significance (Mar 06, 2023)2494751
8-140511537-A-G not specified Uncertain significance (May 23, 2023)2525208
8-140514469-A-G not specified Uncertain significance (Jun 03, 2024)3267108
8-140515161-C-G not specified Uncertain significance (Dec 01, 2022)2365089
8-140515193-A-C not specified Likely benign (Dec 07, 2021)2407839

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CHRAC1protein_codingprotein_codingENST00000220913 35840
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.06950.751114742021147440.00000872
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3495057.40.8710.00000256842
Missense in Polyphen1316.9650.76627253
Synonymous0.4792022.90.8730.00000110233
Loss of Function0.92824.000.4991.67e-763

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000009360.00000925
Middle Eastern0.000.00
South Asian0.00003950.0000376
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Forms a complex with DNA polymerase epsilon subunit POLE3 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome remodeling activity of ISWI/SNF2H and ACF1.;

Recessive Scores

pRec
0.114

Intolerance Scores

loftool
0.561
rvis_EVS
0.57
rvis_percentile_EVS
81.89

Haploinsufficiency Scores

pHI
0.153
hipred
Y
hipred_score
0.705
ghis
0.436

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.961

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Chrac1
Phenotype

Zebrafish Information Network

Gene name
chrac1
Affected structure
primitive erythrocyte differentiation
Phenotype tag
abnormal
Phenotype quality
decreased occurrence

Gene ontology

Biological process
chromatin remodeling;heterochromatin organization involved in chromatin silencing;DNA biosynthetic process
Cellular component
epsilon DNA polymerase complex;CHRAC
Molecular function
DNA binding;DNA-directed DNA polymerase activity;protein binding;protein heterodimerization activity